SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression
Guojun Hou(Shanghai Jiao Tong University), Nan Shen(Cincinnati Children's Hospital Medical Center)
Cited by 69
Related Papers
Identification of Renal Long Non-coding RNA RP11-2B6.2 as a Positive Regulator of Type I Interferon Signaling Pathway in Lupus Nephritis
|Frontiers in Immunology|2019|65
Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery
|Nature Communications|2022|39
miR-744 enhances type I interferon signaling pathway by targeting PTP1B in primary human renal mesangial cells
|Scientific Reports|2015|31
MicroRNA-148a facilitates inflammatory dendritic cell differentiation and autoimmunity by targeting MAFB
|JCI Insight|2020|30
SLE non-coding Genetic Risk Variant Determines the Epigenetic Dysfunction of an Immune Cell Specific Enhancer that Controls Disease-critical microRNA Expression
|bioRxiv (Cold Spring Harbor Laboratory)|2020|15